Hormone-modulating therapy may reduce dementia risk in breast cancer
Jul 25, 2024
The greatest reduction was seen for women aged 65 to 74 years who self-identify as Black.
4.0 percent of seniors had received dementia diagnosis in 2022
Jun 13, 2024
An increase in the percentage with a dementia diagnosis was seen with increasing age; a decrease was seen with an increasing education level.
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
Preeclampsia linked to increased risk for young-onset dementia
May 31, 2024
An even higher risk for young-onset dementia was seen for preeclampsia before 34 weeks of gestation or superimposed on chronic hypertension.
Inappropriate diagnosis of pneumonia common in hospitalized adults
Mar 27, 2024
Inappropriate diagnosis is common, especially in older patients and those with dementia or an altered mental status on presentation.
American Stroke Association, Feb. 7-9
Feb 20, 2024
The conference featured presentations that emphasized basic, clinical and translational medicine and provided insight into the prevention, management and treatment of stroke.
AAN: Dementia more common with essential tremor than in the general population
Mar 08, 2024
Dementia rates, however, were lower than a comparison cohort of people with Parkinson’s disease.
Risk for adverse outcomes increased with antipsychotic use in dementia
Apr 19, 2024
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia and acute kidney injury.
Burden of neurologic diagnoses lower after COVID-19 versus flu
Mar 20, 2024
Postinfection incident neurologic diagnoses were observed in 2.79 and 4.91% of the COVID-19 and influenza cohorts, respectively.